ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-21 |

Results: 21

Safety aspects of pharmacological GH therapy in adults

Authors: Carroll, PV Van den Berghe, G

Citation: Pv. Carroll et G. Van Den Berghe, Safety aspects of pharmacological GH therapy in adults, GROWTH H I, 11(3), 2001, pp. 166-172

Resistance to 2-chloro-2 '-deoxyadenosine of the human B-cell leukemia cell line EHEB

Authors: Cardoen, S Van den Neste, E Smal, C Rosier, JF Delacauw, A Ferrant, A Van den Berghe, G Bontemps, F

Citation: S. Cardoen et al., Resistance to 2-chloro-2 '-deoxyadenosine of the human B-cell leukemia cell line EHEB, CLIN CANC R, 7(11), 2001, pp. 3559-3566

Molecular biology: A timely tool for further unraveling the "diabetes of stress"

Authors: Van den Berghe, G

Citation: G. Van Den Berghe, Molecular biology: A timely tool for further unraveling the "diabetes of stress", CRIT CARE M, 29(4), 2001, pp. 910-911

Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness

Authors: Van den Berghe, G Weekers, F Baxter, RC Wouters, P Iranmanesh, A Bouillon, R Veldhuis, JD

Citation: G. Van Den Berghe et al., Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness, J CLIN END, 86(7), 2001, pp. 3217-3226

Clinical, biochemical and molecular genetic correlations in adenylosuccinate lyase deficiency

Authors: Race, V Marie, S Vincent, MF Van den Berghe, G

Citation: V. Race et al., Clinical, biochemical and molecular genetic correlations in adenylosuccinate lyase deficiency, HUM MOL GEN, 9(14), 2000, pp. 2159-2165

Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia

Authors: Marsin, AS Bertrand, L Rider, MH Deprez, J Beauloye, C Vincent, MF Van den Berghe, G Carling, D Hue, L

Citation: As. Marsin et al., Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia, CURR BIOL, 10(20), 2000, pp. 1247-1255

Novel insights into the neuroendocrinology of critical illness

Authors: Van den Berghe, G

Citation: G. Van Den Berghe, Novel insights into the neuroendocrinology of critical illness, EUR J ENDOC, 143(1), 2000, pp. 1-13

Adenylosuccinase deficiency: an unusual cause of early-onset epilepsy associated with acquired microcephaly

Authors: Nassogne, MC Henrot, B Aubert, G Bonnier, C Marie, S Saint-Martin, C Van den Berghe, G Sebire, G Vincent, MF

Citation: Mc. Nassogne et al., Adenylosuccinase deficiency: an unusual cause of early-onset epilepsy associated with acquired microcephaly, BRAIN DEVEL, 22(6), 2000, pp. 383-386

Prenatal diagnosis in adenylosuccinate lyase deficiency

Authors: Marie, S Flipsen, JWAM Duran, M Poll-The, BT Beemer, FA Bosschaart, AN Vincent, MF Van den Berghe, G

Citation: S. Marie et al., Prenatal diagnosis in adenylosuccinate lyase deficiency, PRENAT DIAG, 20(1), 2000, pp. 33-36

Increased mortality associated with growth hormone treatment in criticallyill adults

Authors: Van den Berghe, G

Citation: G. Van Den Berghe, Increased mortality associated with growth hormone treatment in criticallyill adults, N ENG J MED, 342(2), 2000, pp. 135-135

A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness

Authors: Van den Berghe, G Baxter, RC Weekers, F Wouters, P Bowers, CY Veldhuis, JD

Citation: G. Van Den Berghe et al., A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness, J CLIN END, 85(1), 2000, pp. 183-192

Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model

Authors: Weekers, F Van Herck, E Isgaard, J Van den Berghe, G

Citation: F. Weekers et al., Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model, ENDOCRINOL, 141(11), 2000, pp. 3993-3999

Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2 '-deoxyadenosine

Authors: Bontemps, F Delacauw, A Cardoen, S Van den Neste, E Van den Berghe, G

Citation: F. Bontemps et al., Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2 '-deoxyadenosine, BIOCH PHARM, 59(10), 2000, pp. 1237-1243

Endocrine changes in critically ill patients

Authors: Van den Berghe, G

Citation: G. Van Den Berghe, Endocrine changes in critically ill patients, GROWTH H I, 9, 1999, pp. 77-81

Whither growth hormone in the catabolic state of critical illness?

Authors: Van den Berghe, G

Citation: G. Van Den Berghe, Whither growth hormone in the catabolic state of critical illness?, GROWTH H I, 9(6), 1999, pp. 397-399

Mutation analysis in adenylosuccinate lyase deficiency: Eight novel mutations in the re-evaluated full ADSL coding sequence

Authors: Marie, S Cuppens, H Heuterspreute, M Jaspers, M Tola, EZ Gu, XX Legius, E Vincent, MF Jaeken, J Cassiman, JJ Van den Berghe, G

Citation: S. Marie et al., Mutation analysis in adenylosuccinate lyase deficiency: Eight novel mutations in the re-evaluated full ADSL coding sequence, HUM MUTAT, 13(3), 1999, pp. 197-202

Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2 '-deoxyadenosine

Authors: Van Den Neste, E Bontemps, F Delacauw, A Cardoen, S Louviaux, I Scheiff, JM Gillis, E Leveugle, P Deneys, V Ferrant, A Van den Berghe, G

Citation: E. Van Den Neste et al., Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2 '-deoxyadenosine, LEUKEMIA, 13(6), 1999, pp. 918-925

Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness (vol 140, pg 17, 1999)

Authors: Van den Berghe, G Wouters, P Bowers, CY de Zegher, F Bouillon, R Veldhuis, JD

Citation: G. Van Den Berghe et al., Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness (vol 140, pg 17, 1999), EUR J ENDOC, 140(3), 1999, pp. 268-268

Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness

Authors: Van den Berghe, G Wouters, P Bowers, CY de Zegher, F Bouillon, R Veldhuis, JD

Growth hormone secretagogues in critical illness

Authors: Van den Berghe, G

Citation: G. Van Den Berghe, Growth hormone secretagogues in critical illness, HORMONE RES, 51, 1999, pp. 21-28

Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormonein patients with protracted critical illness

Authors: Van den Berghe, G Wouters, P Weekers, F Mohan, S Baxter, RC Veldhuis, JD Bowers, CY Bouillon, R

Citation: G. Van Den Berghe et al., Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormonein patients with protracted critical illness, J CLIN END, 84(4), 1999, pp. 1311-1323

Risultati: 1-21 |